Assessment of an emergency 14-day (d) integrative supportive care program (14-EISCP) followed by early chemotherapy (CTx) in symptomatic patients (pts) with advanced pancreatic ductal adenocarcinoma (aPDAC): A prospective ARCAD cohort study.

Authors

Benoit Rousseau

Benoit Rousseau

GI Oncology - Memorial Sloan Kettering Cancer Center, New York, NY;

Benoit Rousseau , Antoine Falcoz , Clemence Toullec , Thierry Lecomte , Aurélien Lambert , Christophe Tournigand , Veronique Guerin-Meyer , Christophe Louvet , Isabelle Trouilloud , Yves Rinaldi , Romain Coriat , Jerome Dauba , Cindy Neuzillet , Thierry Andre , Jean-Baptiste Bachet , Jerome Cros , Christelle De La Fouchardiere , Marie-Line Garcia-Larnicol , Aimery De Gramont , Pascal Hammel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Symptoms, Toxicities, and Whole-Person Care

Clinical Trial Registration Number

NCT02979483

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 700)

DOI

10.1200/JCO.2023.41.4_suppl.700

Abstract #

700

Poster Bd #

K7

Abstract Disclosures